A share price of Ekso Bionics Holdings Inc [EKSO] is currently trading at $5.46, down -1.80%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The EKSO shares have gain 12.35% over the last week, with a monthly amount glided 22.15%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Ekso Bionics Holdings Inc experienced fluctuations in its stock price throughout the past year between $2.73 and $14.97. Currently, Wall Street analysts expect the stock to reach $6 within the next 12 months. Ekso Bionics Holdings Inc [NASDAQ: EKSO] shares were valued at $5.46 at the most recent close of the market. An investor can expect a potential return of 9.89% based on the average EKSO price forecast.
Analyzing the EKSO fundamentals
Trailing Twelve Months sales for Ekso Bionics Holdings Inc [NASDAQ:EKSO] were 14.75M which represents 2.37% growth. Gross Profit Margin for this corporation currently stands at 0.53% with Operating Profit Margin at -0.75%, Pretax Profit Margin comes in at -0.71%, and Net Profit Margin reading is -0.71%. To continue investigating profitability, this company’s Return on Assets is posted at -0.48, Equity is -0.91 and Total Capital is -0.87. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.31.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 5.35 points at the first support level, and at 5.23 for the second support level. However, for the 1st resistance point, the stock is sitting at 5.59, and for the 2nd resistance point, it is at 5.71.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Ekso Bionics Holdings Inc [NASDAQ:EKSO] is 1.66. Further, the Quick Ratio stands at 1.09, while the Cash Ratio is 0.3. Considering the valuation of this stock, the price to sales ratio is 1.26, the price to book ratio is 1.48.
Transactions by insiders
Recent insider trading involved Jones Jason C, Chief Operating Officer, that happened on Dec 09 ’25 when 270.0 shares were sold. Chief Financial Officer, Wong Jerome completed a deal on Dec 09 ’25 to sell 1238.0 shares. Meanwhile, Chief Financial Officer Wong Jerome sold 11288.0 shares on Nov 10 ’25.
